during the amikacin phase ( 36 months of average amikacin use of 89 % ; 6048 isolates ) there was no significant change in aminoglycoside resistance except for dibekacin ( from 8.3 % to 10.9 % , 0.05 greater than p greater than 0.02 ) .
C0002499
amikacin
C0002556
aminoglycoside